<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=lupin+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss"><channel><title>lupin pharma - BingNews</title><link>http://www.bing.com/news/search?q=lupin+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>lupin pharma</title><link>http://www.bing.com/news/search?q=lupin+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Lupin Launches Generic Edarbi in US, Secures 180-Day Exclusivity</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2fmedicaldialogues.in%2fnews%2findustry%2fpharma%2flupin-launches-generic-edarbi-in-us-secures-180-day-exclusivity-173147&amp;c=8409273212921912735&amp;mkt=en-us</link><description>Mumbai: Global pharma major Lupin Limited (Lupin) has announced the launch of Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States following the approval from the U.S. FDA for ...</description><pubDate>Thu, 18 Jun 2026 11:15:00 GMT</pubDate><News:Source>Medical Dialogues</News:Source><News:Image>http://www.bing.com/th?id=ONUT.UMA9nrjHGJ-IfNrDCfiaKA&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1500</News:ImageMaxWidth><News:ImageMaxHeight>900</News:ImageMaxHeight></item><item><title>Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2ffinance.yahoo.com%2fsectors%2fhealthcare%2farticles%2flupin-receives-approval-u-fda-203800960.html&amp;c=6704616834747769788&amp;mkt=en-us</link><description>Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that the United States Food and Drug Administration (U.S. FDA) has ...</description><pubDate>Thu, 04 Jun 2026 14:01:00 GMT</pubDate><News:Source>Yahoo Finance</News:Source><News:Image>http://www.bing.com/th?id=ONUT.b04sqI4WApZsxjdJd2sa5g&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>331</News:ImageMaxWidth><News:ImageMaxHeight>400</News:ImageMaxHeight></item><item><title>Lupin Launches Azilsartan Medoxomil Tablets in the United States</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2ffinance.yahoo.com%2fhealthcare%2farticles%2flupin-launches-azilsartan-medoxomil-tablets-155600874.html&amp;c=1131937343935224621&amp;mkt=en-us</link><description>Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Azilsartan Medoxomil Tablets, 40mg and 80mg in the ...</description><pubDate>Wed, 17 Jun 2026 09:52:00 GMT</pubDate><News:Source>Yahoo Finance</News:Source><News:Image>http://www.bing.com/th?id=ONUT.shjahPZ1LiS01l0gAt1jGA&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>331</News:ImageMaxWidth><News:ImageMaxHeight>400</News:ImageMaxHeight></item><item><title>Lupin gains after launching generic hypertension drug in the US</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2fwww.business-standard.com%2fmarkets%2fcapital-market-news%2flupin-gains-after-launching-generic-hypertension-drug-in-the-us-126061800310_1.html&amp;c=6023135649952246288&amp;mkt=en-us</link><description>Lupin rose 1.16% to Rs 2,293.10 after launching Azilsartan Medoxomil Tablets, 40 mg and 80 mg, in the United States following approval of its abbreviated new drug application (ANDA) by the US Food and ...</description><pubDate>Wed, 17 Jun 2026 22:35:00 GMT</pubDate><News:Source>Business Standard</News:Source></item><item><title>Lupin Pharmaceuticals Just Recalled Two Birth Control Pills - Did It Affect The Stock?</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2fwww.forbes.com%2fsites%2fqai%2f2023%2f08%2f07%2flupin-pharmaceuticals-just-recalled-two-birth-control-pillsdid-it-affect-the-stock%2f&amp;c=9112072982804118049&amp;mkt=en-us</link><description>Lupin Pharmaceuticals has recalled two batches of its Tydemy birth control pills after reporting defects The company’s earnings beat reported higher profits and revenues Lupin’s share price rose 4% at ...</description><pubDate>Mon, 07 Aug 2023 05:19:00 GMT</pubDate><News:Source>Forbes</News:Source></item><item><title>Lupin launches generic hypertension drug in the US</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2fwww.business-standard.com%2fmarkets%2fcapital-market-news%2flupin-launches-generic-hypertension-drug-in-the-us-126061700941_1.html&amp;c=6631479048402808909&amp;mkt=en-us</link><description>Lupin announced the launch of Azilsartan Medoxomil Tablets, 40 mg and 80 mg, in the United States following approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...</description><pubDate>Wed, 17 Jun 2026 05:21:00 GMT</pubDate><News:Source>Business Standard</News:Source></item><item><title>Lupin pulls diabetes drug metformin off shelves as carcinogen worries continue to build</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fmanufacturing%2flupin-pulls-diabetes-med-metformin-off-shelves-as-carcinogen-worries-continue-to&amp;c=8348482439610219867&amp;mkt=en-us</link><description>Diabetes med metformin has been in the FDA's crosshairs since the agency found high levels of a probable carcinogen, NDMA, that had already triggered global recalls for Zantac and a commonly used ...</description><pubDate>Wed, 08 Jul 2020 03:40:00 GMT</pubDate><News:Source>FiercePharma</News:Source></item><item><title>Why Lupin, Natco, Mankind and other pharma stocks are down today?</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2fwww.zeebiz.com%2fmarket-news%2fnews-why-lupin-natco-mankind-and-other-pharma-stocks-are-down-today-383881&amp;c=17708453186154837864&amp;mkt=en-us</link><description>The Nifty Pharma index was trading slightly lower at 22,529.20, down 0.23 per cent, reflecting mixed sentiment across healthcare stocks. Despite the broader index weakness, a few constituents managed ...</description><pubDate>Mon, 24 Nov 2025 00:15:00 GMT</pubDate><News:Source>Zee Business</News:Source><News:Image>http://www.bing.com/th?id=ONUT.rTTQnS8UfxzBUwoSk8AvDA&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>675</News:ImageMaxHeight></item><item><title>Lupin Receives USFDA Nod for Interchangeable Ranibizumab Biosimilar Ranluspec</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2fmedicaldialogues.in%2fnews%2findustry%2fpharma%2flupin-receives-usfda-nod-for-interchangeable-ranibizumab-biosimilar-ranluspec-172383&amp;c=15520840050619867759&amp;mkt=en-us</link><description>Mumbai: Global pharma major Lupin Limited (Lupin) has announced that the United States Food and Drug Administration (U.S. FDA) has approved its ranibizumab, Ranluspec (ranibizumab-hkdz), as ...</description><pubDate>Mon, 08 Jun 2026 07:39:00 GMT</pubDate><News:Source>Medical Dialogues</News:Source><News:Image>http://www.bing.com/th?id=ONUT.gla2Y_j5XH6xNElf_wfddw&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1500</News:ImageMaxWidth><News:ImageMaxHeight>900</News:ImageMaxHeight></item><item><title>Oft-chided Lupin dinged by FDA at Indian pharmaceutical ingredients plant</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2foft-chided-lupin-dinged-fda-indian-active-pharmaceutical-ingredients-plant&amp;c=12281965720034629185&amp;mkt=en-us</link><description>In India and elsewhere, Lupin has suffered substantial FDA scrutiny in recent years. (Sarah Silbiger/Stringer/Getty Images News) Lupin is no stranger to FDA rebukes. After facing accusations of ...</description><pubDate>Mon, 18 Apr 2022 06:43:00 GMT</pubDate><News:Source>FiercePharma</News:Source></item><item><title>Lupin partners with Spanish pharma company Laboratorios ERN on respiratory drug, for Spain</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2fwww.thehindubusinessline.com%2fcompanies%2flupin-partners-with-spanish-pharma-company-laboratorios-ern-on-respiratory-drug-for-spain%2farticle71075783.ece&amp;c=928277768671137263&amp;mkt=en-us</link><description>Lupin Limited is partnering with Spanish pharma company Laboratorios ERN SA to launch its fixed dose combination Luforbec (beclometasone/formoterol), in Spain.</description><pubDate>Mon, 08 Jun 2026 01:45:00 GMT</pubDate><News:Source>The Hindu BusinessLine</News:Source><News:Image>http://www.bing.com/th?id=ONUT._el2NHnucZR_OdZA1QEebw&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>675</News:ImageMaxHeight></item><item><title>How Lupin engineered its road to record profits</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3446f87c704634bd2a0d385b4d68c8&amp;url=https%3a%2f%2fwww.businesstoday.in%2fmagazine%2fdeep-dive%2fstory%2fhow-lupin-engineered-its-road-to-record-profits-527743-2026-04-28&amp;c=5289253981260092236&amp;mkt=en-us</link><description>On the evening of February 8, at least 800 people assembled in Mumbai for the launch of Made in India, a biography of Desh Bandhu Gupta (DBG), a chemistry professor who started Lupin Laboratories in ...</description><pubDate>Mon, 27 Apr 2026 17:00:00 GMT</pubDate><News:Source>Business Today</News:Source></item></channel></rss>